溶血性贫血

Go RS, Winters JL, Kay NE. How I treat autoimmune hemolytic anemia. Blood. 2017;129:2971-2979.

• 摘要

Parker C, Omine M, Richards S, et al. Diagnosis and management of paroxysmal nocturnal hemoglobinuria. Blood. 2005;106:3699-3709.

• 全文
• 摘要

Arndt PA, Garratty G. The changing spectrum of drug-induced immune hemolytic anemia. Semin Hematol. 2005;42:137-144.

• 摘要

Bain BJ. Diagnosis from the blood smear. N Engl J Med. 2005;353:498-507.

• 摘要

1.  Beutler E. Red cell enzyme defects. Hematol Pathol. 1990;4:103-114.

• 摘要

2.  Heller P, Best WR, Nelson RB, et al. Clinical implications of sickle-cell trait and glucose-6-phosphate dehydrogenase deficiency in hospitalized black male patients. N Engl J Med. 1979;300:1001-1005.

• 摘要

3.  Prchal JT, Gregg XT. Red cell enzymes. Hematology Am Soc Hematol Educ Program. 2005:19-23.

• 全文
• 摘要

4.  Gehrs BC, Friedberg RC. Autoimmune hemolytic anemia. Am J Hematol. 2002;69:258-271.

• 全文
• 摘要

5.  Go RS, Winters JL, Kay NE. How I treat autoimmune hemolytic anemia. Blood. 2017;129:2971-2979.

• 摘要

6.  Garratty G. Drug-induced immune hemolytic anemia. Hematology Am Soc Hematol Educ Program. 2009:73-79.

• 全文
• 摘要

7.  Laurence J, Wong JE, Nachman R. The cellular hematology of systemic lupus erythematosus. In: Lahita RG, ed. Systemic lupus erythematosus. 2nd ed. New York, NY: Churchill Livingstone; 1992.

8.  Wu Y, Perrotta PL, Snyder EL. Hematopoietic therapy. In: DeVita VT, Hellman S, Rosenberg SA, eds. Cancer: principles and practice of oncology. 7th ed. Philadelphia, PA: Lippincott, Williams and Wilkins; 2005:2402.

9.  Giannini S, Martes C. Anemia in inflammatory bowel disease. Minerva Gastroenterol Dietol. 2006;52:275-291.

• 摘要

10.  Diehl LF, Ketchum LH. Autoimmune disease and chronic lymphocytic leukemia: autoimmune hemolytic anemia, pure red cell aplasia, and autoimmune thrombocytopenia. Semin Oncol. 1998;25:80-97.

• 摘要

11.  Sallah S, Sigounas G, Vos P, et al. Autoimmune hemolytic anemia in patients with non-Hodgkin's lymphoma: characteristics and significance. Ann Oncol. 2000;11:1571-1577.

• 全文
• 摘要

12.  Hoffman PC. Immune hemolytic anemia - selected topics. Hematology Am Soc Hematol Educ Program. 2006:13-18.

• 全文
• 摘要

13.  Ismeno G, Renzulli A, Carozza A, et al. Intravascular hemolysis after mitral and aortic valve replacement with different types of mechanical prosthesis. Int J Cardiol. 1999;69:179-183.

• 摘要

14.  Brown MR, Hasaniya NW, Dang CR. Hemolytic anemia secondary to a porcine mitral prosthetic valve leaflet dissection. Ann Thor Surg. 1995;59:1573-1574.

• 摘要

15.  Enzenauer RJ, Berenberg JL, Cassell PF Jr. Microangiopathic hemolytic anemia as the initial manifestation of porcine valve failure. South Med J. 1990;83:912-917.

• 摘要

16.  Steensma DP, Hoyer JD, Fairbanks VF. Hereditary red blood cell disorders in middle eastern patients. Mayo Clin Proc. 2001;76:285-293.

• 摘要

17.  Ryan K, Bain BJ, Worthington D, et al. Significant haemoglobinopathies: guidelines for screening and diagnosis. Br J Haematol. 2010;149:35-49.

• 全文
• 摘要

18.  Parker C, Omine M, Richards S, et al. Diagnosis and management of paroxysmal nocturnal hemoglobinuria. Blood. 2005;106:3699-3709.

• 全文
• 摘要

19.  Arndt PA, Garratty G. The changing spectrum of drug-induced immune hemolytic anemia. Semin Hematol. 2005;42:137-144.

• 摘要

20.  Johnson ST, Fueger JT, Gottschall JL. One center's experience: the serology and drugs associated with drug-induced hemolytic anemia - a new paradigm. Transfusion. 2007;47:697-702.

• 摘要

21.  Salama A. Drug-induced immune hemolytic anemia. Expert Opin Drug Saf. 2009;8:73-79.

• 摘要

22.  Yiannakopoulou E. Cephalosporin induced haemolytic anaemia in surgical patients: Systematic review. Rev Clin Pharmacol Pharmacokinet. 2008;22:363-365.

23.  Hubl W, Mostbeck B, Hartleb H, et al. Investigation of the pathogenesis of massive hemolysis in a case of Clostridium perfringens septicemia. Ann Hematol. 1993;67:145-147.

• 摘要

24.  Shurin SB, Anderson P, Zollinger J, et al. Pathophysiology of hemolysis in infections with Haemophilus influenzae type b. J Clin Invest. 1986;77:1340-1348.

• 全文
• 摘要

25.  Liesveld JL, Rowe JM, Lichtman MA. Variability of the erythropoietic response in autoimmune hemolytic anemia: analysis of 109 cases. Blood. 1987;69:820-826.

• 全文
• 摘要

26.  Bain BJ. Diagnosis from the blood smear. N Engl J Med. 2005;353:498-507.

• 摘要

27.  Marchand A, Galen RS, Van Lente F. The predictive value of serum haptoglobin in hemolytic disease. JAMA. 1980;243:1909-1911.

• 摘要

28.  Galen RS. Application of the predictive value model in the analysis of test effectiveness. Clin Lab Med. 1982;2:685-699.

• 摘要

29.  Oppenheim A, Jury CL, Rund D, et al. G6PD Mediterranean accounts for the high prevalence of G6PD deficiency in Kurdish Jews. Hum Genet. 1993;91:293-294.

• 摘要

30.  Zecca M, De Stefano P, Nobili B, et al. Anti-CD20 monoclonal antibody for the treatment of severe, immune-mediated, pure red cell aplasia and hemolytic anemia. Blood. 2001;97:3995-3997.

• 全文
• 摘要

31.  Garvey B. Rituximab in the treatment of autoimmune haematological disorders. Br J Haematol. 2008;141:149-169.

• 摘要

32.  Birgens H, Frederiksen H, Hasselbalch HC, et al. A phase III randomized trial comparing glucocorticoid monotherapy versus glucocorticoid and rituximab in patients with autoimmune haemolytic anaemia. Br J Haematol. 2013;163:393-399.

• 摘要

33.  Reynaud Q, Durieu I, Dutertre M, et al. Efficacy and safety of rituximab in auto-immune hemolytic anemia: a meta-analysis of 21 studies. Autoimmun Rev. 2015;14:304-313.

• 摘要

34.  Peñalver FJ, Alvarez-Larrán A, Díez-Martin JL, et al. Rituximab is an effective and safe therapeutic alternative in adults with refractory and severe autoimmune hemolytic anemia. Ann Hematol. 2010;89:1073-1080.

• 摘要

35.  Anderson D, Ali K, Blanchette V, et al. Guidelines on the use of intravenous immune globulin for hematologic conditions. Transfus Med Rev. 2007;21(suppl 1):S9-S56.

• 摘要

36.  Flores G, Cunningham-Rundles C, Newland AC, et al. Efficacy of intravenous immunoglobulin in the treatment of autoimmune hemolytic anemia: results in 73 patients. Am J Hematol. 1993;44:237-242.

• 摘要

37.  Hillmen P, Young NS, Schubert J, et al. The complement inhibitor eculizumab in paroxysmal nocturnal hemoglobinuria. N Engl J Med. 2006;355:1233-1243.

• 全文
• 摘要

38.  Paladio N. Eculizumab for the treatment of paroxysmal nocturnal haemoglobinuria [in Catalan]. Barcelona: Catalan Agency for Health Technology Assessment and Research. 2009. http://www.gencat.cat (last accessed 14 August 2017).

• 全文

39.  Elyassi AR, Rowshan HH. Perioperative management of the glucose-6-phosphate dehydrogenase deficient patient: a review of literature. Anesth Prog. 2009;56:86-91.

• 全文
• 摘要

40.  Meyer O, Stahl D, Beckhove P, et al. Pulsed high-dose dexamethasone in chronic autoimmune haemolytic anaemia of warm type. Br J Haematol. 1997;98:860-862.

• 摘要

41.  Hassoun H, Palek J. Hereditary spherocytosis: a review of the clinical and molecular aspects of the disease. Blood Rev. 1996;10:129-147.

• 摘要

42.  Hoffman PC. Immune hemolytic anemia - selected topics. Hematology Am Soc Hematol Educ Program. 2009:80-86.

• 全文
• 摘要